FARMACOCINETICA DELLA LEVODOPA - Limpe
FARMACOCINETICA DELLA LEVODOPA - Limpe
FARMACOCINETICA DELLA LEVODOPA - Limpe
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Merims D, Djaldetti R, Melamed E (2003)<br />
Waiting for ON: a major problem in patients with Parkinson disease<br />
and ON/OFF motor fluctuations.<br />
Clin Neuropharmacol 26:196-198.<br />
Nilsson D, Hansson LE, Johansson K, Nystrom C, Paalzow L, Aquilonius SM (1998)<br />
Long-term intraduodenal infusion of a water based levodopa-carbidopa dispersion<br />
in very advanced Parkinson's disease.<br />
Acta Neurol Scand 97:175-183.<br />
Nutt JG (1987)<br />
O n - o ff phenomenon: relation to levodopa pharmacokinetics and pharm a c o d y n a m i c s .<br />
Ann Neurol 22:535-540.<br />
Nutt JG, Carter JH, Lea ES, Woodward WR (1997)<br />
Motor fluctuations during continuous levodopa infusions in patients with Parkinson's disease.<br />
Mov Disord 12:285-292.<br />
Nutt JG, Woodward WR, Hammerstad JP, Carter JH, Anderson JL (1984)<br />
The "on-off" phenomenon in Parkinson's disease.<br />
Relation to levodopa absorption and transport.<br />
N Engl J Med 310:483-488.<br />
Nutt JG, Woodward WR, Beckner RM, Stone CK, Berggren K, Carter JH,<br />
Gancher ST, Hammerstad JP, Gordin A (1994)<br />
Effect of peripheral catechol-O-methyltransferase inhibition on the pharmacokinetics<br />
and pharmacodynamics of levodopa in parkinsonian patients.<br />
Neurology 44:913-919.<br />
Obeso JA, Rodriguez-Oroz MC, Chana P, Lera G, Rodriguez M, Olanow CW (2000)<br />
The evolution and origin of motor complications in Parkinson's disease.<br />
Neurology 55:S13-20; discussion S21-13.<br />
Obeso JA, Rodriguez-Oroz M, Marin C, Alonso F, Zamarbide I, Lanciego JL,<br />
Rodriguez-Diaz M (2004)<br />
The origin of motor fluctuations in Parkinson's disease:<br />
importance of dopaminergic innervation and basal ganglia circuits.<br />
Neurology 62:S17-30.<br />
Olanow CW, Agid Y, Mizuno Y, Albanese A, Bonucelli U, Damier P, De Yebenes J,<br />
Gershanik O, Guttman M, Grandas F, Hallett M, Hornykiewicz O, Jenner P,<br />
Katzenschlager R, Langston WJ, LeWitt P, Melamed E, Mena MA, Michel PP, Mytilineou C,<br />
Obeso JA, Poewe W, Quinn N, Raisman-Vozari R, Rajput AH, Rascol O,<br />
Sampaio C, Stocchi F (2004)<br />
Levodopa in the treatment of Parkinson's disease: Current controversies.<br />
Mov Disord 19:997.<br />
Olanow W, Schapira AH, Rascol O (2000)<br />
Continuous dopamine-receptor stimulation in early Parkinson's disease.<br />
Trends Neurosci 23:S117-126.<br />
Stocchi F, Olanow CW (2004)<br />
Continuous dopaminergic stimulation in early and advanced Parkinson's disease.<br />
Neurology 62:S56-63.<br />
Stocchi F, Vacca L, Ruggieri S, Olanow CW (2005)<br />
Intermittent vs continuous levodopa administration in patients<br />
with advanced Parkinson disease: a clinical and pharmacokinetic study.<br />
Arch Neurol 62:905-910.